Dr. Hughes will speak on October 3rd at the The Stem Cell Summit
October 2-3, 2007 in Boston
Sponsored by Harvard Stem Cell Institute, Genetics Policy Institute, and Burrill Life Sciences Media Group
BOSTON—(BUSINESS WIRE)—Harvard Stem Cell Institute, Genetics Policy Institute, and Burrill Life Sciences Media Group, a joint venture of Nielsen Business Media and Burrill & Company, will host a landmark event focusing on the future of stem cell research and its potential to advance treatments for millions suffering from devastating medical conditions.
Announcing a stellar line-up of scientific and policy leaders participating in the event and a unique conference agenda, The Stem Cell Summit will illuminate the complex, but fascinating, implications of this cutting-edge biotechnology. Researchers, clinicians, patients, key policy-makers, industry leaders, investors, philanthropists, legal experts, bioethicists, students, political strategists and advocates will all find something of value at this one-of-a-kind conference. The Stem Cell Summit will take place on October 2-3 at the Hynes Convention Center in Boston, MA.
Participating scientific and policy leaders include:
Douglas Melton, Co-Director, Harvard Stem Cell Institute
Ian Wilmut, Centre for Regenerative Medicine, University of Edinburgh
Rudolf Jaenisch, Whitehead Institute and MIT
John Gearhart, Johns Hopkins University School of Medicine
George Daley, Harvard Stem Cell Institute, Children’s Hospital Boston
Camillo Ricordi, Diabetes Research Institute
James T. Willerson, University of Texas Health Science Center
Leonard Zon, Harvard Stem Cell Institute, Children’s Hospital Boston
Lawrence S. B. Goldstein, UC San Diego
Janet Rossant, University of Toronto
Stephen Livesey, Australian Stem Cell Centre
Raphael Hofstein, Hadasit, Israel
John A. Kessler, Northwestern University
Bob Klein, California Institute for Regenerative Medicine
The agenda includes breakout sessions where researchers and patients will have a chance to speak with leading scientists and policy makers about the ways in which stem cell research may impact the quest for cures. Sessions will focus on diabetes, cancer, spinal cord injury and paralysis, cardiovascular disease, aging and Parkinson’s, ALS and neurological disorders.
The summit will feature the Conversations with Expert’s Luncheon where leading experts join conference delegates for in depth discussions on all aspects of business, law, research, ethics and policy. In addition, the Patient Advocate’s Roundtable Breakfast will provide a forum on how the stem cell debates are changing the current political landscape.
Other unique aspects of the program include The Hospital Perspective - The HSCI Case Study, and special panels on investment, biotechnology and global collaboration. A large exhibit hall will feature displays from business, research centers and country and state pavilions.
Some of the special events include a poster session for ethics, law and policy; The Stem Cell Summit Awards Dinner presented by the Genetics Policy Institute, and networking receptions for speakers and delegates.
The conference chairs for the summit are Bernard Siegel, Executive Director of the Genetics Policy Institute; David Scadden co-director of the Harvard Stem Cell Institute and Director of the Center for Regenerative Medicine at MGH and G. Stephen Burrill, CEO, Burrill & Company.
The conference is sponsored and supported by Alexandria Real Estate Equities, Inc., BD Biosciences, Angioblast Systems, Mesoblast Ltd., Fish & Richardson P.C., Darby & Darby, Scottish Development International, Sidley Austin, LLP. ViaCell, Inc., Stem Cell Network-Canada, Kennedy Covington Lobdell & Hickman, LLP., Juvenile Diabetes Research Foundation (JDRF), Engene, Hadassah, New York Stem Cell Foundation, Nixon Peabody LLP., BioE, Australian Government- Invest Australia, Australian Stem Cell Centre, StemCore, Organogenisis, WiCell Foundation and BioSpherix.
About Genetics Policy Institute (GPI)
GPI is the catalyst of the “Pro-Cures Movement,” a global coalition of pro-research stakeholders. Through GPI’s meetings, publications, press relations, web site, speaker’s bureau and teaching initiatives, GPI educates the public, media and key decision-makers on critical issues. GPI analyzes the law and regulations relating to all aspects of regenerative medicine with an eye to removing bottlenecks, while maintaining rigorous ethical oversight. For more information please visit: www.genpol.org or call 305-801-4928.
About Harvard Stem Cell Institute
The Harvard Stem Cell Institute (HSCI) was formed in 2004 with the mission of fulfilling the promise of stem cell biology to develop therapies for a wide range of chronic medical conditions. HSCI is comprised of the eight schools of Harvard University and its eleven affiliated hospitals and research institutions incorporating over 100 faculty. In addition to scientific and clinical research, HSCI has specific programs in ethics and public policy and public education. For more information please visit: www.hsci.harvard.edu or call 617-496-4050.
About Burrill Life Sciences Media Group
Burrill Life Sciences Media Group, a joint venture of Burrill & Company and Nielsen Business Media, produces worldwide life sciences conferences, Biotech-2007, bio-intelligence reports, and The Journal of Life Sciences, with the California Health Institute. Biotech-2007, an annual book on the “State of the Industry,” has been an important part of the biotech industry’s view of itself over the last 20 years.
About Nielsen Business Media
Nielsen Business Media, a division of The Nielsen Company, is a leading market-focused provider of integrated information and sales and marketing solutions, helping businesses go to market more effectively and efficiently.
Serving seven major market groups, and 30 industries, spanning the entertainment, media and marketing, retail, travel and performance, design, and life sciences industries, Nielsen Business Media provides business-to-business products and services in print, online and in person.
With 42 publications, over 135 trade shows and conferences, and 185 digital products and services, Nielsen Business Media offers insight, analysis and face-to-face contacts to help professionals better understand their markets, serve their customers and grow their businesses.
Contact:
Genetics Policy Institute
Bernard Siegel, 305-801-4928
bernard@genpol.org
or
Nielsen / Burrill Life Sciences Media Group
Marisa Grimes, 646-654-5759
marisa.grimes@nielsen.com
IEET Blog